vs
EyePoint, Inc.（EYPT）与Quanterix Corp（QTRX）财务数据对比。点击上方公司名可切换其他公司
Quanterix Corp的季度营收约是EyePoint, Inc.的70.8倍（$43.9M vs $619.0K）。Quanterix Corp净利率更高（-52.7% vs -10922.3%，领先10869.6%）。Quanterix Corp同比增速更快（24.7% vs -94.7%）。Quanterix Corp自由现金流更多（$-16.5M vs $-66.0M）。过去两年Quanterix Corp的营收复合增速更高（16.9% vs -77.0%）
EyePoint制药公司总部位于马萨诸塞州沃特敦，是一家专注于将微机电系统（MEMS）与纳米技术应用于给药领域的专业医药企业，依托前沿交叉技术开发创新给药方案，聚焦眼科等领域的药物递送技术创新与产品开发。
Quanterix Corp是一家生命科学企业，研发、生产和销售超高灵敏度单分子检测诊断平台、试剂及检测服务，覆盖肿瘤、神经退行性疾病、传染病等领域，为全球科研机构、生物制药企业及临床实验室提供研究、药物开发及临床诊断相关支持。
EYPT vs QTRX — 直观对比
营收规模更大
QTRX
是对方的70.8倍
$619.0K
营收增速更快
QTRX
高出119.4%
-94.7%
净利率更高
QTRX
高出10869.6%
-10922.3%
自由现金流更多
QTRX
多$49.5M
$-66.0M
两年增速更快
QTRX
近两年复合增速
-77.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $619.0K | $43.9M |
| 净利润 | $-67.6M | $-23.1M |
| 毛利率 | — | 45.7% |
| 营业利润率 | -11364.3% | -56.4% |
| 净利率 | -10922.3% | -52.7% |
| 营收同比 | -94.7% | 24.7% |
| 净利润同比 | -63.3% | -98.8% |
| 每股收益（稀释后） | $-0.82 | $-0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EYPTQTRX
| Q4 25 | $619.0K | $43.9M | ||
| Q3 25 | $966.0K | $40.2M | ||
| Q2 25 | $5.3M | $24.5M | ||
| Q1 25 | $24.5M | $30.3M | ||
| Q4 24 | $11.6M | $35.2M | ||
| Q3 24 | $10.5M | $35.8M | ||
| Q2 24 | $9.5M | $34.4M | ||
| Q1 24 | $11.7M | $32.1M |
净利润EYPTQTRX
| Q4 25 | $-67.6M | $-23.1M | ||
| Q3 25 | $-59.7M | $-33.5M | ||
| Q2 25 | $-59.4M | $-30.0M | ||
| Q1 25 | $-45.2M | $-20.5M | ||
| Q4 24 | $-41.4M | $-11.6M | ||
| Q3 24 | $-29.4M | $-8.4M | ||
| Q2 24 | $-30.8M | $-7.4M | ||
| Q1 24 | $-29.3M | $-11.2M |
毛利率EYPTQTRX
| Q4 25 | — | 45.7% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 46.2% | ||
| Q1 25 | — | 54.1% | ||
| Q4 24 | — | 63.0% | ||
| Q3 24 | 93.0% | 56.3% | ||
| Q2 24 | 85.2% | 64.7% | ||
| Q1 24 | 93.5% | 57.8% |
营业利润率EYPTQTRX
| Q4 25 | -11364.3% | -56.4% | ||
| Q3 25 | -6420.8% | -92.8% | ||
| Q2 25 | -1166.8% | -151.6% | ||
| Q1 25 | -199.7% | -86.9% | ||
| Q4 24 | -390.4% | -42.0% | ||
| Q3 24 | -311.2% | -32.8% | ||
| Q2 24 | -364.5% | -31.8% | ||
| Q1 24 | -285.2% | -47.3% |
净利率EYPTQTRX
| Q4 25 | -10922.3% | -52.7% | ||
| Q3 25 | -6183.4% | -83.3% | ||
| Q2 25 | -1114.3% | -122.6% | ||
| Q1 25 | -184.8% | -67.6% | ||
| Q4 24 | -357.3% | -33.1% | ||
| Q3 24 | -279.0% | -23.3% | ||
| Q2 24 | -325.3% | -21.5% | ||
| Q1 24 | -250.6% | -34.8% |
每股收益（稀释后）EYPTQTRX
| Q4 25 | $-0.82 | $-0.48 | ||
| Q3 25 | $-0.85 | $-0.73 | ||
| Q2 25 | $-0.85 | $-0.77 | ||
| Q1 25 | $-0.65 | $-0.53 | ||
| Q4 24 | $-0.65 | $-0.30 | ||
| Q3 24 | $-0.54 | $-0.22 | ||
| Q2 24 | $-0.58 | $-0.19 | ||
| Q1 24 | $-0.55 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.1M | $29.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $306.1M | $295.7M |
| 总资产 | $364.0M | $418.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EYPTQTRX
| Q4 25 | $306.1M | $29.8M | ||
| Q3 25 | $204.0M | $38.3M | ||
| Q2 25 | $255.7M | $132.9M | ||
| Q1 25 | $318.2M | $76.5M | ||
| Q4 24 | $370.9M | $56.7M | ||
| Q3 24 | $253.8M | $29.3M | ||
| Q2 24 | $280.2M | $47.0M | ||
| Q1 24 | $299.3M | $45.3M |
股东权益EYPTQTRX
| Q4 25 | $306.1M | $295.7M | ||
| Q3 25 | $200.2M | $314.5M | ||
| Q2 25 | $246.0M | $292.5M | ||
| Q1 25 | $298.4M | $316.4M | ||
| Q4 24 | $336.5M | $330.0M | ||
| Q3 24 | $218.7M | $338.9M | ||
| Q2 24 | $228.3M | $340.8M | ||
| Q1 24 | $249.9M | $343.4M |
总资产EYPTQTRX
| Q4 25 | $364.0M | $418.8M | ||
| Q3 25 | $251.7M | $444.1M | ||
| Q2 25 | $301.1M | $375.6M | ||
| Q1 25 | $362.6M | $396.5M | ||
| Q4 24 | $418.5M | $406.5M | ||
| Q3 24 | $300.9M | $411.0M | ||
| Q2 24 | $324.2M | $415.9M | ||
| Q1 24 | $329.2M | $414.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-65.0M | $-16.4M |
| 自由现金流经营现金流 - 资本支出 | $-66.0M | $-16.5M |
| 自由现金流率自由现金流/营收 | -10667.7% | -37.7% |
| 资本支出强度资本支出/营收 | 159.3% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-243.4M | $-80.0M |
8季度趋势，按日历期对齐
经营现金流EYPTQTRX
| Q4 25 | $-65.0M | $-16.4M | ||
| Q3 25 | $-59.4M | $-41.2M | ||
| Q2 25 | $-62.6M | $-5.7M | ||
| Q1 25 | $-53.1M | $-13.9M | ||
| Q4 24 | $-35.8M | $-4.3M | ||
| Q3 24 | $-39.0M | $-5.7M | ||
| Q2 24 | $-20.2M | $-5.0M | ||
| Q1 24 | $-31.2M | $-20.2M |
自由现金流EYPTQTRX
| Q4 25 | $-66.0M | $-16.5M | ||
| Q3 25 | $-60.2M | $-41.9M | ||
| Q2 25 | $-63.8M | $-6.4M | ||
| Q1 25 | $-53.4M | $-15.1M | ||
| Q4 24 | $-36.2M | $-4.7M | ||
| Q3 24 | $-40.6M | $-6.6M | ||
| Q2 24 | $-21.1M | $-6.5M | ||
| Q1 24 | $-32.4M | $-20.7M |
自由现金流率EYPTQTRX
| Q4 25 | -10667.7% | -37.7% | ||
| Q3 25 | -6226.9% | -104.2% | ||
| Q2 25 | -1196.5% | -26.3% | ||
| Q1 25 | -218.4% | -49.9% | ||
| Q4 24 | -312.7% | -13.4% | ||
| Q3 24 | -385.8% | -18.4% | ||
| Q2 24 | -222.4% | -19.1% | ||
| Q1 24 | -277.0% | -64.5% |
资本支出强度EYPTQTRX
| Q4 25 | 159.3% | 0.2% | ||
| Q3 25 | 82.6% | 1.7% | ||
| Q2 25 | 22.9% | 3.2% | ||
| Q1 25 | 1.1% | 4.1% | ||
| Q4 24 | 3.3% | 1.2% | ||
| Q3 24 | 15.0% | 2.4% | ||
| Q2 24 | 9.5% | 4.7% | ||
| Q1 24 | 10.2% | 1.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EYPT
暂无分部数据
QTRX
| Products | $29.2M | 67% |
| Consumable And Other Products | $12.7M | 29% |
| Service Type Warranties | $1.7M | 4% |
